Cognitive Remediation and Sheltered Employment in Schizophrenia

Chronic Schizophrenia Clinical Trial

— RemedRehab  

Official title:

Specific Cognitive Remediation for Schizophrenia (RECOS) and Sheltered Employment: a Multicentre Controlled Randomized Trial.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01891929
• Other study ID #: 2012-A01676-37
• Status: Completed
• Phase: N/A
• Start date: July 2013
• Est. completion date: October 22, 2018

Study information

• Verified date: February 2019
• Source: Hôpital le Vinatier
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study, driven on schizophrenic patients, is aimed at :

1. Measuring the efficiency of the cognitive remediation program RECOS (COgnitive REmediation in Schizophrenia) on the capacity of the patients suffering from schizophrenia to improve the integration in sheltered employment (ESAT and EA).

2. Comparing the efficiency of the program of cognitive remediation RECOS (RECOS arm) to the one of an usual program of coverage/care (TAU arm = Treatment As Usual) on integration in sheltered employment of patients suffering from schizophrenia.

3. Realizing a comparative analysis, in both arms, of :

1. the number of working hours achieved in sheltered environment during the 6 months following the two programs (reported to the working time planned by the contract of employment)

2. the duration of such employments in sheltered areas.

4. Estimating the impact of RECOS on the neuropsychological variables, the symptomatology, the consciousness of the disorders(insight), the quality of life and the social autonomy before the treatment (month M0), at the end of the treatment (month M3), and 6 months later (month M9), and looking for a correlation between the improvement of these parameters and sheltered employment.

5. Estimating the impact of cognitive remediation on integration in sheltered employment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 79
• Est. completion date: October 22, 2018
• Est. primary completion date: October 22, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• Age from 18 to 50 years.

• Schizophrenia according to the criteria of the DSM-IV-TR.

• Project of entry to ESAT or to EA in the 6 weeks which follow.

• IQ > 70 (F-NART).

• Stable symptomatology during the month preceding the inclusion.

• Psychotropic treatment unchanged during the month preceding the inclusion (change no more than 25 % posology).

• Overdrawn performances in at least one of the 6 functions estimated by the kit of neuropsychological tests.

• French mother tongue.

• Informed and signed consent by the patient.

• Agreement of the guardian (for protected adults).

• Membership in a national insurance scheme.

Exclusion Criteria:

• Dependence and recent abuses of cannabis (> 2 / week) or in any other substance (according to the criteria of the DSM-IV-TR), except tobacco.

• Neurological disorders of vascular, infectious or neurodegenerative origin; dyschromatopsie.

• Taking of medicine with somatic tropism having a cerebral or psychic impact (eg:

corticoids).

• Simultaneous participation to any other program of remediation targeting the neurocognitive deficits.

• Resistance to neuroleptic.

• Reading and writing not acquired.

Related Conditions & MeSH terms

• Chronic Schizophrenia
• Schizophrenia

Intervention

Behavioral:
• RECOS (COgnitive REmediation for Schizophrenia)
Every RECOS patient will benefit, with his therapist, from 2 sessions of 1 hour of training per week over a 14 weeks period (M1 to M3), plus 1 hour per week of task to be realized at home. All in all, it is thus about a training period of 42 hours. After remediation, the follow-up of the patient will be led by his therapist with monthly appointments during 6 months (M4 to M9). In parallel, neuropsychological and clinical scores will be assessed before (M0) and after the training period (M3), as well as at the end of the study (M9). Working and relational abilities will be assessed at the beginning and at the end of the working period (M4 and M9).
• TAU (Treatment As Usual)
The treatment of the group TAU (Treatment As Usual) will consist of the usual care proposed by every service of the various inquiring centers involved. No additional session will be proposed. In parallel, neuropsychological and clinical scores will be assessed before (M0) and after the training period (M3), as well as at the end of the study (M9). Working and relational abilities will be assessed at the beginning and at the end of the working period (M4 and M9).

Locations

Country	Name	City	State
France	Hôpital Le Vinatier Pôle Centre	Bron
France	Hôpital Le Vinatier Pôle Est	Bron
France	Mental Health Center (MGEN)	Lille
France	Hôpital Ste Marguerite	Marseille
France	Nantes University Hospital	Nantes
France	Centre Hospitalier de Niort	Niort
France	Hôpital Ste Anne	Paris
France	Centre Hospitalier Henri Laborit	Poitiers
France	Mental Health Center (MGEN)	Rueil-Malmaison
France	Saint-Cyr Hospital	Saint-Cyr-au-Mont-d'Or
France	Centre Hospitalier de St-Egrève	Saint-Egrève
France	Centre de Santé Mentale Angevin (CESAME)	Sainte-Gemmes-sur-Loire
France	Tours University Hospital	Tours

Sponsors (11)

Lead Sponsor	Collaborator
Hôpital le Vinatier	Centre Hospitalier de Niort, Centre Hospitalier Henri Laborit, Clermont-de-l’Oise Hospital (Clermont-de-l’Oise), Mental Health Center MGEN (Lille), Mental Health Center MGEN (Rueil-Malmaison), Nantes University Hospital, Saint-Egrève Hospital (Saint-Egrève), Sainte Anne Hospital (Paris), Sainte-Marguerite Hospital (Marseille), University Hospital, Tours

Country where clinical trial is conducted

France, 

References & Publications (2)

Deppen P, Sarrasin Bruchez P, Dukes R, Pellanda V, Vianin P. [Cognitive remediation program for individuals living with schizophrenia (Recos): preliminary results]. Encephale. 2011 Sep;37(4):314-21. doi: 10.1016/j.encep.2011.02.002. Epub 2011 Apr 9. French. — View Citation

Franck N, Duboc C, Sundby C, Amado I, Wykes T, Demily C, Launay C, Le Roy V, Bloch P, Willard D, Todd A, Petitjean F, Foullu S, Briant P, Grillon ML, Deppen P, Verdoux H, Bralet MC, Januel D, Riche B, Roy P; Other members of the Cognitive Remediation Network, Vianin P. Specific vs general cognitive remediation for executive functioning in schizophrenia: a multicenter randomized trial. Schizophr Res. 2013 Jun;147(1):68-74. doi: 10.1016/j.schres.2013.03.009. Epub 2013 Apr 9. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of worked hours during the first 6 months of the contract of employment	Compared evolution in both arms (RECOS and TAU) of the number of worked hours, with regard to the number of hours planned in the contract of employment, during the 6 months following the entry in sheltered working environment (i.e. an external, validated and strong measure of the capacity of the patient to fit professionally).	Outcome measures are daily assessed during 6 months (M4 to M9)
Secondary	Compared evolution of the neuropsychological and clinical balance sheets between the beginning and the end of the Cognitive Remediation period (or the end of the "Treatment As Usual" period for the TAU arm)	Compared evolution, in both arms (RECOS and TAU) of the scores obtained in the different neuropsychological tests, and in the scales of clinical symptomatology (PANSS, questionnaires of insight, self-respect, well being, social autonomy, and cognitive complaint) at the moment of the inclusion (month M0), early after the training period of Cognitive Remediation or Treatment as Usual (M3), and 6 month after (M9).	Scores are assessed 3 times: at M0 (Inclusion), at M3 (after Cognitive Remediation or Treatment As Usual), and at M9 (6 month after end of treatment).
Secondary	Compared evolution of the neuropsychological and clinical balance sheets during the 6 first months of working contract (i.e. following the end of the training Cognitive Remediation period or after the "Treatment As Usual" period for the TAU arm).	Compared evolution, in both arms (RECOS and TAU) of the scores obtained in the different neuropsychological tests, and in the scales of occupational integration (EATR), clinical symptomatology (PANSS, questionnaires of insight, self-respect, well being, social autonomy, and cognitive complaint) after the training period of Remediation and at the moment of the entry in sheltered working environment (month M3), and 6 months later (month M9).	Neuropsychological and clinical scores are assessed twice : at M3 (after Cognitive Remediation or Treatment As Usual), and at M9 (after 6 months of working period). Occupational integration (EATR) is assessed twice at the same moments (M3 & M9).